DAFTAR PUSTAKA

1. B. Kahle, H. J. Hermanns, and G. Gallenkemper, “Evidence based treatment of chronic leg

ulcer,” Deutsches Arzteblatt International, vol. 108, no. 14, pp. 231-237, 2011.
2. C. S. Sasanka, “Venous ulcers of the lower limb: where do we stands?” Indian Journal of
Plastic Surgery, vol. 45, no. 2, pp. 266-274, 2012.
3. Evaluation and management of lower extremity ulcer (jurnal DUI)
4. Platelet rich fibrin : a new generation platelet concentrate
5. 6th International Conference on Clinical and Experimental Dermatology
6. Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment
of refractory leg ulcers: a prospective cohort study
7. Garg A, Levin NA, Bernhard D. Structure of Skin Lesions and Fundamental of Clinical Diagnosis.
In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors.
Fitzpatrick’s Dermatology In General Medicine. 8th ed. New York: McGraw-Hill Medical; 2012.
p. 26-42.
8. Buku IKKK UI edisi 7
9. Chronic Leg Ulcers: Epidemiology, Aetiopathogenesis, and Management
Shubhangi Vinayak Agale
Department of Pathology, Grant Govt Medical College, Byculla, Mumbai
400008, India
Received 18 November 2012; Revised 24 March 2013; Accepted 3 April 2013
10. Overview leg ulcers (arterial and venous) http/ vascularcenter
11. Study of the pathogenesis and diagnosis of ulcer of lower extremity under various conditions
Gajjam Shrinivas A.1 *, Wagh Amol
12. H. Newton, “Leg ulcers: differences between venous and arterial,” Wounds Essentials, vol.
6, no. 1, pp. 20–28, 2011
13. Chouckroun J. Adda F. Schoeffler C. vevelle A. Une opportunite en paro implantologie:
Le PRF. Implantodontie 2001; 42, 55-62
14. S Giannini, A cielo, L bonanome, c rastelli. Comparison between PRP, PRGF, and PRF:
light and shadows in three similar but different ,European review for medical and
phamacologocal sciences. 2015;19:927-930
15. Clinical use of GF in the improvement of skin wound healing, 2014, sarita mac
16. Mehta S, Watson JT. Platelet rich concentrate: basic science and current clinical applications. J
Orthop Trauma. 2008; 22:433-8.
17. Dohan Ehrenfest DM, Bielecki T, Mishra A, Borzini P, et al. In serach of a consensus for surgical
use: PRP, PRF, fibrin gel polymerization and leucocytes, curr pharm biotechnol. 2012;13: 1131-
1137

17
18. Saldalamacchia G. Lapice E, Cuomo V, de Feo E, et al. A controlled study of the uce of
autologous platelet gel fo the treatment of diabetic foot ulcer. Nutr Metab Cardiovasc Dis.
2004;14:395-6
19. Comparison of efficacy of autologous Platelet rich fibrin versus saline dressing in chronic
venous leg ulcer: a randomized controlled trial. Anirudh somani and reena rai
20. Guo S, DiPietro LA. Factor affecting wound healing. J Dent Res. 2010; 89(3): 219-229.

21. Morton LM, Phillips TJ. Wound healing and treating wounds. J Am Acad Dermatol. 2016; 74:
589-605.

22. Sussman C. Assessment of the patient, skin, and wound. In: Sussman C, Bates BM, editors. Wound
Care a Collaborative Practice Manual for Health Professionals. 4th ed. Philadelphia: Lippincott
Williams and Wilkins; 2012. p. 53-105.

Dilaporkan bahwa Platelet-Rich Fibrin memiliki beberapa kelebihan dibandingkan dengan

Platelet-Rich Plasma (PRP) seperti persiapan yang lebih mudah, murah dan relatif cepat,
tidak memerlukan tambahan antikoagulan dan memberikan hasil penyembuhan yang
baik.14,15
 Chouckroun J. Diss A, simonpieri A, girard MO, . Schoeffler , Dohan SL, et al.
Platelet ricf fibrin (PRF): a second generation platelete concentrate: part I:
technological concepts and evaluation. Oral surg oral med pathol oral radiol endod.
2006; 101 : E37-34
 Sunitha Raja V, Muniratham Naidu E. Platelet Rich fibrin I Fibrin: Evolution of
second generation platelet concentrate. Indian J Dent Res, 2008; vol. 19: 42-46

18